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Abstract
Background: Tumor cells interact with the cells of the microenvironment not only by cell-cell-contacts but also by the 
release of signal substances. These substances are known to induce tumor vascularization, especially under hypoxic 
conditions, but are also supposed to provoke other processes such as tumor innervation and inflammatory conditions. 
Inflammation is mediated by two organ systems, the neuroendocrine system and the immune system. Therefore, we 
investigated the influence of substances released by PC-3 human prostate carcinoma cells on SH-SY5Y neuroblastoma 
cells as well as neutrophil granulocytes and cytotoxic T lymphocytes, especially with regard to their migratory activity.
Results: PC-3 cells express several cytokines and growth factors including vascular endothelial growth factors, 
fibroblast growth factors, interleukins and neurotrophic factors. SH-SY5Y cells are impaired in their migratory activity by 
PC-3 cell culture supernatant, but orientate chemotactically towards the source. Neutrophil granulocytes increase their 
locomotory activity only in response to cell culture supernantant of hypoxic but not of normoxic PC-3 cells. In contrast, 
cytotoxic T lymphocytes do not change their migratory activity in response to either culture supernatant, but increase 
their cytotoxicity, whereas supernatant of normoxic PC-3 cells leads to a stronger increase than that of hypoxic PC-3 
cells.
Conclusions: PC-3 cells release several signal substances that influence the behavior of the cells in the tumor's 
microenvironment, whereas no clear pattern towards proinflammatory or immunosuppressive conditions can be seen.
Introduction
Today's understanding of the biology of tumors increas-
ingly shows a crucial role of the microenvironment in the
tumors' growth and the course of the cancer disease. This
environmental interactions concern the development of
new blood vessels in tumors (called neoangiogenesis),
which was one of the first tumor-stroma interactions
described in 1971 by Judah Folkman and colleagues [1],
as well as similarly the development of new lymph vessels
(lymphangiogenesis) [2], and the innervation of tumors,
which we have termed neoneurogenesis [3,4]. Because of
strong similarities to tissue growth and regeneration,
tumors are regarded as wounds that do not heal [5]. A
further argument for a comparison of tumors and
wounds is the presence of cells of the immune system as
well as fibroblasts infiltrating tumors being redolent of
inflammatory conditions. Such parallels have already
been observed by Virchow back in 1863, and this hypoth-
esis of a non-healing wound has been seized and refined
by Balkwill and Mantovani [6]. An inflammatory milieu is
regarded as beneficial for a tumor in several aspects, con-
cerning the growth as well as the migratory activity of
tumor cells [7], which is a prerequisite for invasion and
metastasis formation [8].
Two organ systems provide pro-inflammatory signal
substances. Predominantly, there are of course the cells of
the immune system, that release cytokines and chemok-
ines which provoke inflammatory effect. However, the
immune system is under the superordinate regulation of
the nervous system, and the nervous system itself releases
substances that play a role in inflammation. Thus, the
above mentioned neoneurogenesis - the innervation of
tumor tissue - might facilitate pro-inflammatory events
in two ways: either directly by the release of neurotrans-
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mitters that act on the tumor cells (e.g. substance P, bra-
dykinin, calcitonin gene-related peptide) [9], or indirectly
by an action on leukocytes that release such factors in
response.
But what causes the presence of leukocytes and the
innervation of a tumor? It is well documented that tumor
cells release a plethora of signal substances including
chemoattractive molecules [10]. This release is a regu-
lated process, e.g. by hypoxic conditions [11]. The lack of
oxygen and nutrition provokes the tumor cells to release
substances that initiate the above described three related
processes: neoangiogenesis, lymphangiogenesis, and neo-
neurogenesis [3]. However, most studies on the tumor-
environment interactions aim to the understanding of
tumor vascularisation, and less attention has been paid to
the mechanisms of tumor innervation and leukocyte
infiltration. Therefore, we investigated by the use of the
prostate carcinoma cell line PC-3 the tumor interactions
with cells of the nervous system on the example of SH-
SY5Y human neuroblastoma cells and with cells of the
immune system on the example of neutrophil granulo-
cytes and cytotoxic T lymphocytes (CTLs), especially
with regard to the migratory activity of these cells. Migra-
tion is one essential cell function for nerve cells to inner-
vate the tumor and for leukocytes to extravasate from the
blood and infiltrate the tumor tissue.
Methods
Cell isolation and cell culture
Human CTLs and neutrophil granulocytes were isolated
from peripheral blood of voluntary healthy donors as
described previously [12]. Heparinized blood was diluted
with PBS (1:1.7). Neutrophil granulocytes together with
erythrocytes were separated from the lymphocyte-con-
taining peripheral blood mononuclear cell fraction by a
density gradient centrifugation on lymphocyte separation
medium (LSM 1077; PAA, Pasching, Austria). Subse-
quently, the neutrophil granulocytes were further isolated
from the pellet of the centrifugation. The pellet was
mixed with platelet-depleted serum from the same blood
donor and diluted by 1:1.3 with a high molecular weight
dextran solution (Macrodex; Fresenius, Bad Homburg,
Germany) containing 0.01 M EDTA. After 3 hours, the
supernatant containing granulocytes was isolated and
remaining erythrocytes were removed by a hypotonic
lysis with 0.3% sodium chloride on ice. The neutrophil
granulocytes were used for experiments immediately
after isolation.
The CTLs were positively selected from the mononu-
clear cell fraction of the density gradient centrifugation
by immunomagnetic beads, which were coated with
mouse anti-human CD8 monoclonal antibodies (Dyna-
beads; Invitrogen, Karlsruhe, Germany). The mononu-
clear cell fraction was incubated with the beads for 10
minutes at 4°C. Bead-bound cells were isolated by eight
times washing with Dulbecco's PBS (PAA) in a magnetic
field. After that, the beads were removed from the iso-
lated CTL using Detachabeads (Invitrogen) at incubation
for 45 minutes at 20°C. The CTLs were kept in culture
overnight with RPMI culture medium (PAA) containing
10% heat-inactivated fetal calf serum (PAA) and 1% peni-
cillin/streptomycin solution (50 U/ml and 50 μg/ml,
respectively; GIBCO, Eggenstein-Leopoldshafen, Ger-
many) at 37°C in a humidified atmosphere containing 5%
CO2.
The isolated CTLs were activated by anti-CD3 and
anti-CD28 antibodies (both BD Pharmingen, Erembode-
gem, Belgium) as described previously [13]. Twenty-four-
well plates were coated with 10 μg/ml of each of these
antibodies in 1 ml PBS at 4°C over night. Cells were
seeded at a concentration of 8 × 105 cells/ml in culture
medium as described above. The cells were incubated for
three days, with the daily addition of 150 ng/ml IL-2
(Invitrogen, Nivelles, Belgium). Maximum activation of
the cells (as measured by the activation markers CD25
and CD45R0) was reached after four days, but the granu-
larity (as measured by the sideward scatter) reached the
maximum already after three days and decreased to day
four.
PC-3 human prostate carcinoma cells (DSMZ, Braun-
schweig, Germany) were cultured in HAMs and RPMI
medium (1:1) containing 10% heat-inactivated fetal calf
serum (PAA) and 1% penicillin/streptomycin solution (50
U/ml and 50 μg/ml, respectively; GIBCO) at 37°C in a
humidified atmosphere containing 5% CO2. Hypoxia was
induced by a stepwise oxygen-deprivation in hypoxia-
chambers (Billups-Rothenberg, Del Mar, CA): PC-3 cells
were kept two days at 10% O2, one day at 5% O2, and one
day at 1% O2 with constantly 5% CO2 and the remainder
being N2.
SH-SY5Y human neuroblastoma cells (ATCC, Rock-
ville, MA) were cultured in DMEM medium (PAA) con-
taining 10% heat-inactivated fetal calf serum (PAA) and
1% penicillin/streptomycin solution (50 U/ml and 50 μg/
ml, respectively; GIBCO) at 37°C in a humidified atmo-
sphere containing 5% CO2. The cells were differentiated
to fully neurotrophic factor-dependent neuron-like cells
by treatment for five days with 10 μM retinoic acid (RA;
Sigma-Aldrich, Taufkirchen, Germany) and used for
experiments immediately after differentiation.
Cell migration experiments
We performed our conventional three-dimensional, col-
lagen-based migration assay as described in detail previ-
ously [12]. In brief, a suspension of 2.5 × 105 leukocytes or
8 × 104 SH-SY5Y cells or PC-3 cells in 50 μl RPMI was
mixed with 100 μl of a buffered collagen solution (pHVoss et al. Cell Communication and Signaling 2010, 8:17
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7.4), containing 1.67 mg/ml bovine collagen type I (Invit-
rogen, Cohesion Technologies, Palo Alto, CA). The sus-
pension was filled into self constructed migration
chambers, which consisted of a microscopic glass slide,
wax walls, and a cover slip on top. After polymerization
of the collagen at 37°C in a humidified 5% CO2 atmo-
sphere, concerning the leukocytes, the remaining cham-
ber volume was filled with medium containing the
investigated substances (medium conditioned with sub-
stances released by normoxic or hypoxic PC-3 cells), or,
concerning the SH-SY5Y cells a second collagen matrix
was applied next to the first one in the same manner as
described above. This second collagen matrix contained 8
× 104 PC-3 cells. The migration of the cells was recorded
by time-lapse videomicroscopy for 1 hour (leukocytes) or
for 15 hours (SH-SY5Y and PC-3 cells) at 37°C. The paths
of 30 randomly selected cells were digitized by computer-
assisted cell tracking and the part of migratory active cells
was calculated for each one minute or 15 minute interval.
Statistically significant changes were calculated from the
mean migratory activities in the steady state phase using
the unpaired and undirected Student's t  test; p-value
lower than 0.05 was regarded as statistically significant.
Gene expression profiling
In order to analyze changes of the gene expression in PC-
3 cells in response to SH-SY5Y cells, these cells were co-
cultured without having direct cell-cell contact. For these
experiments cell culture inserts for 6-well plates were
used (8.0 μm pore size; Becton Dickinson, Le Pont De
Claix, France). PC-3 cells (5 × 105) were cultured in the
bottom of the 12-well plates, and SH-SY5Y cells (2 × 105)
were cultured in the inserts. Empty inserts served as con-
trol. After 24 hours incubation, the total RNA of the PC-3
cells was isolated using a NucleoSpin RNA II kit (Mach-
ery&Nagel, Dueren, Germany). Real-time analysis of the
gene expression of PC-3 cells (1 μg RNA per sample) was
performed using the RT2  Profiler PCR Array System
(SABiosciences, Frederick, MD) according to the manu-
facturer's protocol and an Abi Prism 7700 Sequence
Detector (Applied Biosystems, Weiterstadt, Germany).
Gene sets of the human growth factor kit and the human
tumor metastasis kit were used.
Cyotoxicity assay
The lytic activity of CTLs was analyzed by a colorimetric,
non-radioactive cytotoxicity assay (Promega, Mannheim,
Germany), which quantitatively measures the release of
lactate dehydrogenase (LDH) after cell lysis according to
Jurisic et al. [14], and as described previously [15]. K562
human myeloid leukemia cells (DSMZ, Braunschweig,
Germany) were used as target cells. In the assay, the PC-3
cell culture supernatants were added to the CTLs imme-
d i a t e l y  b e f o r e  i n c u b a t i o n  w i t h  t a r g e t  c e l l s.  N o n - c o n d i -
tioned medium served as control. The effectors were
used at an effector:target ratio of 10:1. Cells were co-incu-
bated for 4 h at 37°C, the supernatants were collected and
the LDH release was evaluated by a colorimetric reaction
(absorbance at 490 nm). The percentage of lysis was cal-
culated by comparing the LDH released for each lysis
condition maximal LDH release.
Results
Effects of signal substances derived from PC-3 cells on SH-
SY5Y neuroblastoma cells
We have reported previously that PC-3 prostate carci-
noma cells have influence on the SH-SY5Y neuroblas-
toma cells with regard to their differentiation by the
release of signal substances [16]. However, we have in this
previous work focussed on the expression of some neu-
ronal growth factors. Therefore, we analyzed in a much
broader range by real-time RT-PCR, which signal sub-
stances are expressed by tumor cells. We performed these
analyses either without any stimulus or with culture
supernatant that was conditioned with SH-SY5Y neuro-
blastoma cells. PC-3 human prostate carcinoma cells
express several cytokines of the growth factor and inter-
leukin group as well as chemokines (Fig. 1). With our
arrays, we have detected 41 of these substances, whose
expression is differentially regulated upon treatment with
SH-SY5Y cell culture supernatant. Most noticeable is the
large number of fibroblast growth factors (FGFs) that are
expressed. FGF-1, -5 and -11 are down-regulated after 24
treatment of the PC-3 cells with SH-SY5Y conditioned
medium, whereas the expression of FGF-2, -7, -9, -13, -
17, -22 and -23 remains unchanged, and the expression of
FGF-9, -14 and -19 increases (Fig. 1). Furthermore, PC-3
cells express growth differentiation factors (GDF-8, -10, -
11), vascular endothelial growth factors (VEGF A and C),
as well as growth factor that are more specific for the ner-
vous system, i.e. the nerve growth factor (NGF) beta, the
brain-derived neurotrophic factor (BDNF), the glial cell
line-derived neurotrophic factor (GDNF), and neurotro-
phin-3. Among the interleukins are IL-1alpha and beta, -
2, -3, -4, -11, -12beta and -18. In summary, the PC-3 pros-
tate carcinoma cells express a bunch of signal molecules
that might influence the growth and differentiation of
nerve cells and that furthermore facilitate the develop-
ment of an inflammatory milieu in the tumor environ-
ment. Therefore, we investigated the migration of SH-
SY5Y cells under the influence of the PC-3 cells' secreted
factors. Surprisingly, the migratory activity of SH-SY5Y
was strongly impaired under influence of PC-3 cell condi-
tioned medium (Fig. 2A). The migratory activity of undif-
ferentiated SH-SY5Y was significantly (p < 0.001) reduced
from 37.6% ± 7.1% to 15.0% ± 6.4% migrating cells, and
the migratory activity of SH-SY5Y cells that were differ-
entiated with retinoic acid was significantly (p < 0.001)Voss et al. Cell Communication and Signaling 2010, 8:17
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reduced from 39.0% ± 8.0% to 11.1% ± 4.2% migrating
cells, as was analyzed from the migratory activity within
the time-frame 720 to 900 minutes (Fig. 2A). However,
although the overall migratory activity was reduced, the
SH-SY5Y orientated chemotactically towards the PC-3
cells, when those cells were present in an adjacent colla-
gen matrix (Fig. 2B). Furthermore, the spreading of SH-
SY5Y cells increased in response to PC-3 culture super-
natant (Fig. 2C). The cells were significantly (p < 0.001)
longer by 27% when treated with the PC-3-conditioned
medium. In summary, PC-3 cells mutually interact with
SH-SY5Y cells: PC-3 cells release signal substances that
affect the SH-SY5Y cell migration, and the SH-SY5Y in
turn modify the expression of these signal substances in
PC-3 cells.
The raising question is, whether the PC-3 cells them-
s e l v e s  m i g h t  b e  a f f e c t e d  i n  t h e i r  m i g r a t o ry  a c t i v i t y  b y
their own signal substances or by those of the SH-SY5Y
cells. Cell culture supernatant of SH-SY5Y cells had influ-
ence on the gene expression, as shown in Fig. 1, but did
not influence the migratory activity of the PC-3 cell (Fig.
3A). Furthermore, we have reported previously that
hypoxic conditions lead to a change of the released sub-
stances' profile of PC-3 cells towards more inflammatory
conditions similar to SH-SY5Y cells, e.g. by an increase of
the release of interleukin-1 [17]. However, in this previ-
ous publication we have shown that oxygen-deprived PC-
3 cells significantly increase their migratory activity [17].
We have extended these experiments on PC-3 cells, and
have added samples of normoxic PC-3 cells that were
treated with cell culture supernatant of hypoxic PC-3
cells in order to see if these released factors may work in
an autocrine manner (Fig. 3B). Interestingly, culture
supernatant of hypoxic PC-3 cells slightly reduced the
migratory activity of PC-3 cells that were kept under nor-
moxic conditions from 27.4% ± 15.4% to 18.2% ± 12.4%
migrating cells, whereas hypoxic PC-3 cells significantly
(p = 0.019) increase their migratory activity to 54.0% ±
11.5% migrating cells (Fig. 3B). This result is insofar inter-
esting, as the released signal substances of hypoxic PC-3
cells are not the stimulus for the migratory activity. Thus,
oxygen-deprivation must directly induce an intracellular
signalling pathway that stimulates migration. However,
the cell culture supernatant has an effect on the morphol-
ogy of the PC-3 cells (Fig. 3C). Under normal culture con-
ditions, PC-3 cells are spherical or spindle-shaped. When
treated with cell culture supernantant of hypoxic PC-3
cells, the normoxic cells change their morphology and
look similar to PC-3 cells that are kept under hypoxic
conditions. The cells develop very long pseudopodia (Fig.
3C). The observed inhibition of PC-3 cell migration by
hypoxic conditioned cell culture medium is not due to an
over-stimulation by high concentrations of signal sub-
stances, since dilutions of the conditioned medium by
1:10 and 1:100 had no effect on the migratory activity
(data not shown).
Effects of signal substances from PC-3 cells on leukocytes
An important skill of cells that are involved in wound
healing and inflammation is the ability to migrate. Leuko-
cytes have to enter these wounded or inflamed sites from
the blood stream by passing the vascular endothelial cells
in order to eliminate pathogens and fully accomplish this
tissue's functionality. As mentioned above, leukocytes are
frequently found in tumors. Neutrophil granulocytes and
macrophages can make up to 50 percent of the total
tumor mass in breast carcinoma [18], and neutrophil
granulocytes are supposed to play a role in inflammation-
induced angiogenesis [19,20].
Cell culture supernatant of PC-3 cells that were kept
under normal conditions had no effect on the migratory
activity of neutrophil granulocytes (Fig. 4A), but when
the PC-3 cells were kept under hypoxic conditions, the
Figure 1 Gene expression analysis of cytokines and chemokines 
in PC-3 human prostate carcinoma cells in response to SH-SY5Y 
cell culture supernatant. Downregulation of a gene to less than the 
half of the expression in control cells, and upregulation to more than 
the double were accepted as significant changes (vertical lines).
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migratory activity of the neutrophil granulocytes was sig-
nificantly (p < 0.001) increased from 16.0% ± 10.3% to
60.2% ± 11.8% migrating cells. In contrast, the migratory
activity of neither naïve nor activated CTLs was influ-
enced by normoxic or hypoxic cell culture supernatant,
whereas the overall migratory activity of activated CTLs
was higher than of naïve cells (27.4% ± 4.7% compared to
15.3% ± 14.3% migrating cells; Fig. 4B and 4C). However,
the cytotoxic activity of these cells was significantly influ-
enced by signal substances of PC-3 cells (Fig. 5A and 5B).
Cell culture supernatant of PC-3 cells that were kept
under normoxic conditions significantly (p < 0.001)
increased the lytic activity of naïve CTLs from 4.9 ± 3.8
percent of the maximal lysis to 65.5 ± 1.6 percent.
Hypoxic cell culture supernatant significantly (p < 0.001)
reduced this activity down to 37.8 ± 1.0 percent (Fig. 5A).
Activated CTLs showed an overall higher lytic activity
than naïve CTLs. The lysis of these cells significantly (p =
0.001) increased from 40.3 ± 11.1 percent of the control
to 90.1 ± 3.8 percent with normoxic PC-3 cell culture
supernatnant. Hypoxic cell culture supernatant signifi-
cantly (p = 0.013) reduced this activity down to 75.6 ± 4.5
percent (Fig. 5B). In summary, PC-3 cells release various
signal substances under normoxic and hypoxic condi-
tions, which have divergent effects on the function of leu-
kocytes.
It would be of course of interest, if in a more complex
setting the mutual interaction of SH-SY5Y cells with PC-
Figure 2 Changes of the migratory activity of SH-SY5Y human neuroblastoma cells in response to PC-3 cell-conditioned medium. A and B: 
the migratory activity and directionality of migration was analyzed by means of the collagen-based three-dimensional assay utilizing time-lapse vid-
eomicroscopy. In A, the graph shows the mean value of three independent experiments (90 cells were analyzed per sample); in B, the graph shows 
the summary and mean value of four independent experiments (120 cells were analyzed). The arrow indicates the source of substances released by 
PC-3 cells. C: the images show the morphology of the SH-SY5Y cells. Mean values and standard deviation of the cells' lengths were calculated from 
sizing 120 cells per sample.
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Figure 3 Migratory activity of PC-3 prostate carcinoma cells in response to cell culture supernatant of SH-SY5Y cells (A), and hypoxic PC-3 
cells (B). The left graphs show the time-course of the migratory activity. The right graphs show the corresponding time-average and the standard 
deviation of four independent experiments with cells from different donors (120 cells have been analyzed per sample). SN = supernatant (of cell cul-
tures). Asterisks indicate statistically significant changes. In C, the images show the morphology of the cells corresponding to the conditions of (B)
A (SH-SY5Y supernatant)
B (hypoxic supernatant)
* *
*
C
Normoxic PC-3 Normoxic PC-3 with Hyp-SN Hypoxic PC-3Voss et al. Cell Communication and Signaling 2010, 8:17
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Figure 4 Migratory activity of neutrophil granulocytes and CTLs in response to cell culture supernatant of either normoxic or hypoxic PC-
3 cells. The left graphs show the time-course of the migratory activity. The right graphs show the corresponding time-average and the standard de-
viation of three independent experiments with cells from different donors (90 cells have been analyzed per sample). Asterisks indicate statistically sig-
nificant changes.
A (NG)
B (naive CTL)
*
C (activated CTL)Voss et al. Cell Communication and Signaling 2010, 8:17
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3 cells might also affect the function of the leukocytes.
However, such experiments were started but brought no
definite result so far. As one can understand, this is
largely based on the fact, that we can treat either cell type
(SH-SY5Y cells or PC-3 cells) with culture medium of the
other cell type, respectively, but we can subsequently not
separate the substances released by these two cell types.
Therefore, we have always a mixed effect on the leuko-
cytes with high variations and have thus abandoned from
presenting results on this.
Discussion
Although it is currently a focus in cancer research, how
hypoxia changes the profile of expressed and released sig-
nal substances, especially with regard to neoangiogenesis
[21-23], it is frequently reported that tumor cells release
several signal substances even under normoxic condi-
tions either constitutively or in response to other stimuli
than hypoxia [24-27] including substances that have
especially impact on nerve cells [28]. We show herein that
the PC-3 cells change the expression profile of signal sub-
stances not only in response to hypoxia, as reported pre-
viously [17], but also in response to other cells such as the
nerve-like SH-SY5Y cells. Such a mutual exchange of sig-
nals might facilitate the innervation of the tumor. Our
gene expression analysis has shown that several FGFs are
expressed, which are known to be involved at least in
neoangiogenesis and lymphangiogenesis [29,30]. As doc-
umented before, these two processes have a common reg-
ulation with neoneurogenesis [3], and we thus argue that
the nerve cells themselves contribute to the regulation of
tumor innervation. It has been shown before that tumors
release neurotrophic factors [31-33], and the presence of
neuroendocrine markers in tumors is correlated with a
poor prognosis in colorectal cancer [34,35]. It is notewor-
thy that the neurotransmitter norepinephrine strongly
enhances the migratory activity of PC-3 cells [36], and
leads to an increased metastasis development in mice
[37]. Furthermore, prostate cancer cells invade and
spread along nerve fibres, a process known as perineural
invasion, which is correlated with a worse outcome in
patients [38,39]. Therefore, the innervation of a tumor
might support tumor progression by the release of prom-
igratory neurotransmitters such as norepinephrine and
the guidance of cells away from the primary tumor. How-
ever, one final note is that the SH-SY5Y not constitutively
release substances that induce migration of PC-3 cells, as
shown in Fig. 5A.
As written above, tumors are often described as
w o u n d s  t h a t  d o  n o t  h e a l  [ 8 ] .  I n  c o n t r a s t,  t u m o r s  m a y
induce immune dysfunction [40], e.g. by the release of
immunosuppressive substances such as interleukin-10
[41], or by an active counter-attack that induces apoptosis
in the tumor-infiltrating leukocytes [42]. In addition to
the above discussed induction of metastasis formation,
the innervation of tumors might support a proinflamma-
tory milieu by the release of the according neurotransmit-
ters. For example, peptidergic nerve fibres have been
found in esophageal and cardiac carcinoma [43]. In that
study, substantial amounts of substance P have been
found, which is a key mediator of inflammatory processes
[44].
With regard to the interaction of the PC-3 cells with
leukocytes, the substances released by the tumor cells do
not provide a clear picture that points either to an inflam-
mation-like immune stimulation or a to tumor-promot-
ing immunosuppression in terms of a tumor escape
mechanism. The expression of interleukin-10 is reduced
in the presence of SH-SY5Y cells, whereas the expression
of interleukin-1β is increased (Fig. 1). As reported previ-
ously, the expression of both interleukin-1α and β was
enhanced under hypoxic conditions, too [17].
In terms of the leukocyte function, the migration of
neutrophil granulocytes, but not of CTLs was stimulated
solely by hypoxic PC-3 cell culture supernatant, whereas
the normoxic cell culture supernatant has no effect on
Figure 5 Lysis of naïve (A) and activated (B) CTLs in response to 
PC-3 cell culture supernatants. The cytotoxic activity of the CTLs was 
analyzed by the release of lactate dehydrogenase from lysed K562 
cells. The columns show mean values and standard deviation of four 
(A) and three (B) experiments. Asterisks indicate statistically significant 
changes.
A (naive CTL)
B (activated CTL)
* *
* *Voss et al. Cell Communication and Signaling 2010, 8:17
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either cell type. This would be a sign of a rather inflam-
matory milieu, but in contrast, such a hypoxic milieu
reduces the cytotoxicity of CTLs, which is simulated by
the normoxic cell culture supernatant. However, a large
number of substances that are released by the PC-3 cells
have been described to modulate the function of immune
cells, either alone or in combination. We are thus not able
to attribute the observed effects to one single substance
or a close circle of these substances. For example, the
increase of interleukin-1β release in response to SH-SY5Y
cells or hypoxia might explain the increase in the migra-
tory activity of neutrophil granulocytes [45], but even
other ligands whose expression has not been investigated
here, might be responsible for this effect.
Finally, concerning the tumor cells themselves, there
are some lines of evidence that the cells stimulate their
migratory activity in an autocrine manner [46-49],
including interleukin-1α and β [50], as well as FGF-5 [51],
which are released by the PC-3 cells, too. Although the
migratory activity of PC-3 cells significantly increases
under hypoxic conditions, this is not due to such an auto-
crine effect (Fig.3B). In contrast, the substances released
by hypoxic PC-3 cells slightly reduce the migratory activ-
ity of normoxic cells. Thus, hypoxia or its mediator, the
transcription factor HIF (hypoxia inducible factor),
directly activate an intracellular signalling pathway in the
PC-3 cells, which induces migratory activity independent
of an autocrine action of the released signal substances.
In a broader view, this increase of migratory is important
with regard to anti-angiogenic or angiostatic cancer
treatment. Such treatments have been implemented in
therapy protocols in order to cut off the tumor from
nutrients and thereby stop its growth or ultimately pro-
voke cell death. However, there is an increasing number
of publications that report about an aggravation of the
course of the cancer disease with respect to metastasis
formation by the use of such therapeutics, and in light of
these reports anti-angiogenesis has maybe to be revisited
[52]. The herein presented stimulation of migratory activ-
ity by oxygen deprivation might deliver an explanation for
these evil side-effects of anti-angiogenic drugs.
Conclusions
It is well established that a growing tumor interacts with
its microenvironment in order to accomplish nutrient
supply, disposal of metabolites, and innervation. In this
regard, a tumor behaves like any physiologically growing
tissue. However, it still remains obscure, how these sub-
stances that are released by tumor cells in concert trigger
an immune response. Hypotheses generally point to an
inflammatory situation in tumors. Our results show that
the signal substances released by PC-3 human prostate
carcinoma cells have the potential to stimulate the inner-
vation of a tumor, and that various leukocyte functions
are affected. However, we have not seen a clear picture
towards a proinflammatory process. Our functional
investigations rather provide a chaotic picture with
regard to the regulation of the immune system, which
supports a view of a tumor escape by immune dysregula-
tion.
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